Labcorp Holdings LH shares are up, up 1.46%, on Thursday as the company reported strong first-quarter results and raised its ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) announced in Q1 CY2026, with sales up 5.8% year on year to $3.54 ...

Labcorp's revenue grew to $3.54 billion in Q1 2026 as the company's strategy of acquiring outreach laboratory businesses from ...

Labcorp Holdings Inc (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the first quarter ended March 31, 2026 and updated full-year guidance.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Here's how Labcorp, the ...

(1) 2025 Updated guidance includes an impact from foreign currency translation of 0.4%. (2) Enterprise level revenue is presented net of intersegment transaction eliminations. (3) 2025 Updated ...

Oct 24 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Good day, and thank you for standing by. Welcome to the Q3 2025 Labcorp Holdings Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

Laboratory Corporation of America Holdings LH, or Labcorp, is poised for growth in the upcoming quarters due to its series of strategic acquisitions and partnerships. The company is nearing its ...